Supplementation with Alpha-Tocopherol and Ascorbic Acid to Nonalcoholic Fatty Liver Disease’s Statin Therapy in Men

Oxidative stress and inflammation contribute to the pathogenesis and progression of nonalcoholic fatty liver disease (NAFLD), and the control of lipid status by statins may help to stop the progression of NAFLD. We hypothesized that the addition of antioxidant vitamins C and E to atorvastatin therap...

Full description

Saved in:
Bibliographic Details
Main Authors: Nikola Hadzi-Petrushev, Katerina Dimovska, Nikola Jankulovski, Dine Mitrov, Mitko Mladenov
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Advances in Pharmacological Sciences
Online Access:http://dx.doi.org/10.1155/2018/4673061
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562891201445888
author Nikola Hadzi-Petrushev
Katerina Dimovska
Nikola Jankulovski
Dine Mitrov
Mitko Mladenov
author_facet Nikola Hadzi-Petrushev
Katerina Dimovska
Nikola Jankulovski
Dine Mitrov
Mitko Mladenov
author_sort Nikola Hadzi-Petrushev
collection DOAJ
description Oxidative stress and inflammation contribute to the pathogenesis and progression of nonalcoholic fatty liver disease (NAFLD), and the control of lipid status by statins may help to stop the progression of NAFLD. We hypothesized that the addition of antioxidant vitamins C and E to atorvastatin therapy is associated with improved serum enzyme antioxidant status. NAFLD-related serum parameters and the activity of antioxidant enzymes, before and after 3 months of treatment, were determined in patients receiving atorvastatin alone or atorvastatin plus antioxidants. Compared to healthy controls, the patients, before receiving therapy, had increased catalase and glutathione reductase, with no significant difference in glutathione peroxidase activity. After the treatment, the levels of all three antioxidant markers were reduced to the same degree in both groups of patients, indicating therapy-induced lower level of reactive oxygen species production and/or improved nonenzymatic antioxidant mechanisms. Both therapies led to the normalization of the serum lipid profile and aminotransferase levels in the patients, but the reduction in CRP, although significant, did not reduce levels to those of the controls. The obtained results favor the notion that therapy with atorvastatin alone is equally efficient during the early stages of NAFLD, regardless of the addition of antioxidant vitamins. This trial is registered with TCTR20180425001.
format Article
id doaj-art-96a98ef7b33d40fca1efac2e8d14cc70
institution Kabale University
issn 1687-6334
1687-6342
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Advances in Pharmacological Sciences
spelling doaj-art-96a98ef7b33d40fca1efac2e8d14cc702025-02-03T01:21:35ZengWileyAdvances in Pharmacological Sciences1687-63341687-63422018-01-01201810.1155/2018/46730614673061Supplementation with Alpha-Tocopherol and Ascorbic Acid to Nonalcoholic Fatty Liver Disease’s Statin Therapy in MenNikola Hadzi-Petrushev0Katerina Dimovska1Nikola Jankulovski2Dine Mitrov3Mitko Mladenov4Department of Physiology, Faculty of Natural Sciences and Mathematics, “Ss. Cyril and Methodius” University, Skopje, MacedoniaDepartment of Physiology, Faculty of Natural Sciences and Mathematics, “Ss. Cyril and Methodius” University, Skopje, MacedoniaDepartment of Abdominal Surgery, Faculty of Medicine, “Ss. Cyril and Methodius” University, Skopje, MacedoniaDepartment of Radiology and Physical Therapy and Department of Internal Diseases in Ruminants, Faculty of Veterinary Medicine, “Ss. Cyril and Methodius” University, Skopje, MacedoniaDepartment of Physiology, Faculty of Natural Sciences and Mathematics, “Ss. Cyril and Methodius” University, Skopje, MacedoniaOxidative stress and inflammation contribute to the pathogenesis and progression of nonalcoholic fatty liver disease (NAFLD), and the control of lipid status by statins may help to stop the progression of NAFLD. We hypothesized that the addition of antioxidant vitamins C and E to atorvastatin therapy is associated with improved serum enzyme antioxidant status. NAFLD-related serum parameters and the activity of antioxidant enzymes, before and after 3 months of treatment, were determined in patients receiving atorvastatin alone or atorvastatin plus antioxidants. Compared to healthy controls, the patients, before receiving therapy, had increased catalase and glutathione reductase, with no significant difference in glutathione peroxidase activity. After the treatment, the levels of all three antioxidant markers were reduced to the same degree in both groups of patients, indicating therapy-induced lower level of reactive oxygen species production and/or improved nonenzymatic antioxidant mechanisms. Both therapies led to the normalization of the serum lipid profile and aminotransferase levels in the patients, but the reduction in CRP, although significant, did not reduce levels to those of the controls. The obtained results favor the notion that therapy with atorvastatin alone is equally efficient during the early stages of NAFLD, regardless of the addition of antioxidant vitamins. This trial is registered with TCTR20180425001.http://dx.doi.org/10.1155/2018/4673061
spellingShingle Nikola Hadzi-Petrushev
Katerina Dimovska
Nikola Jankulovski
Dine Mitrov
Mitko Mladenov
Supplementation with Alpha-Tocopherol and Ascorbic Acid to Nonalcoholic Fatty Liver Disease’s Statin Therapy in Men
Advances in Pharmacological Sciences
title Supplementation with Alpha-Tocopherol and Ascorbic Acid to Nonalcoholic Fatty Liver Disease’s Statin Therapy in Men
title_full Supplementation with Alpha-Tocopherol and Ascorbic Acid to Nonalcoholic Fatty Liver Disease’s Statin Therapy in Men
title_fullStr Supplementation with Alpha-Tocopherol and Ascorbic Acid to Nonalcoholic Fatty Liver Disease’s Statin Therapy in Men
title_full_unstemmed Supplementation with Alpha-Tocopherol and Ascorbic Acid to Nonalcoholic Fatty Liver Disease’s Statin Therapy in Men
title_short Supplementation with Alpha-Tocopherol and Ascorbic Acid to Nonalcoholic Fatty Liver Disease’s Statin Therapy in Men
title_sort supplementation with alpha tocopherol and ascorbic acid to nonalcoholic fatty liver disease s statin therapy in men
url http://dx.doi.org/10.1155/2018/4673061
work_keys_str_mv AT nikolahadzipetrushev supplementationwithalphatocopherolandascorbicacidtononalcoholicfattyliverdiseasesstatintherapyinmen
AT katerinadimovska supplementationwithalphatocopherolandascorbicacidtononalcoholicfattyliverdiseasesstatintherapyinmen
AT nikolajankulovski supplementationwithalphatocopherolandascorbicacidtononalcoholicfattyliverdiseasesstatintherapyinmen
AT dinemitrov supplementationwithalphatocopherolandascorbicacidtononalcoholicfattyliverdiseasesstatintherapyinmen
AT mitkomladenov supplementationwithalphatocopherolandascorbicacidtononalcoholicfattyliverdiseasesstatintherapyinmen